109 related articles for article (PubMed ID: 9614919)
1. Characterization of 5q deletions by subtelomeric probes and spectral karyotyping.
Ning Y; Liang JC; Nagarajan L; Schröck E; Ried T
Cancer Genet Cytogenet; 1998 Jun; 103(2):170-2. PubMed ID: 9614919
[No Abstract] [Full Text] [Related]
2. Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization.
Tosi S; Giudici G; Rambaldi A; Scherer SW; Bray-Ward P; Dirscherl L; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Mar; 24(3):213-21. PubMed ID: 10451701
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.
Douet-Guilbert N; De Braekeleer E; Basinko A; Herry A; Gueganic N; Bovo C; Trillet K; Dos Santos A; Le Bris MJ; Morel F; Eveillard JR; Berthou C; De Braekeleer M
Leukemia; 2012 Jul; 26(7):1695-7. PubMed ID: 22290067
[No Abstract] [Full Text] [Related]
4. Cryptic 6q subtelomeric deletion associated with a paracentric inversion in a mildly retarded child.
Lorda-Sanchez I; Lopez-Pajares I; Roche MC; Sanz R; Rodriguez de Alba M; Gonzalez-Gonzalez MC; Ibañez A; Ramos C; Ayuso C
Am J Med Genet; 2000 Dec; 95(4):336-8. PubMed ID: 11186887
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
Gao Q; Horwitz M; Roulston D; Hagos F; Zhao N; Freireich EJ; Golomb HM; Olopade OI
Genes Chromosomes Cancer; 2000 Jun; 28(2):164-72. PubMed ID: 10825001
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification.
Knutsen T; Pack S; Petropavlovskaja M; Padilla-Nash H; Knight C; Mickley LA; Ried T; Elwood PC; Roberts SJ
Genes Chromosomes Cancer; 2003 Jul; 37(3):270-81. PubMed ID: 12759925
[TBL] [Abstract][Full Text] [Related]
7. Karyotype refinement in five patients with acute myeloid leukemia using spectral karyotyping.
Calabrese G; Fantasia D; Spadano A; Morizio E; Di Bartolomeo P; Palka G
Haematologica; 2000 Nov; 85(11):1219-21. PubMed ID: 11064476
[No Abstract] [Full Text] [Related]
8. A half cryptic derivative der(18)t(5;18)pat identified by M-FISH and subtelomere probes: clinical findings and review of subtelomeric rearrangements.
Reddy KS; Fugate JK
Clin Genet; 1999 Oct; 56(4):328-32. PubMed ID: 10636453
[No Abstract] [Full Text] [Related]
9. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
[TBL] [Abstract][Full Text] [Related]
11. Subtelomeric fish findings in Turkish patients with idiopathic mental retardation.
Tos T; Vurucu S; Karkucak M; Kozan S; Gul D; Akin R
Genet Couns; 2013; 24(3):259-64. PubMed ID: 24341139
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
[TBL] [Abstract][Full Text] [Related]
13. Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.
Breccia M; Cannella L; Latagliata R; Nanni M; Santopietro M; Loglisci G; Ferretti A; Barzotti R; Oliva EN; Alimena G
Leuk Res; 2011 Jun; 35(6):e69-70. PubMed ID: 21232796
[No Abstract] [Full Text] [Related]
14. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of multiple color spectral karyotyping in detecting small interchromosomal rearrangements.
Fan YS; Siu VM; Jung JH; Xu J
Genet Test; 2000; 4(1):9-14. PubMed ID: 10794355
[TBL] [Abstract][Full Text] [Related]
17. Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
Herry A; Douet-Guilbert N; Guéganic N; Morel F; Le Bris MJ; Berthou C; De Braekeleer M
Ann Hematol; 2006 Apr; 85(4):244-9. PubMed ID: 16425025
[TBL] [Abstract][Full Text] [Related]
18. Treatment of deletion 5q acute myeloid leukemia with lenalidomide.
Lancet JE; List AF; Moscinski LC
Leukemia; 2007 Mar; 21(3):586-8. PubMed ID: 17230228
[No Abstract] [Full Text] [Related]
19. Chromosome healing of constitutional chromosome deletions studied by microdissection.
Vermeesch JR; Falzetti D; Van Buggenhout G; Fryns JP; Marynen P
Cytogenet Cell Genet; 1998; 81(1):68-72. PubMed ID: 9691179
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 5q subtelomeric deletion syndrome.
Rauch A; Dörr HG
Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):372-6. PubMed ID: 17910075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
